Two repurposed drugs and a blue dye show potential as SARS-CoV-2 entry inhibitors

By | April 26, 2021
A new multidisciplinary study from Australia, published in the open-access journal mBio, shows that three compounds used to treat cystic fibrosis, dry eye, and a specific medical dye may lead to future strategies for the treatment of coronavirus disease (COVID-19).